Trem2 Rat Monoclonal Antibody [Clone ID: 6E9]
CAT#: AM26305PU-N
Trem2 rat monoclonal antibody, clone 6E9, Purified
Need it in bulk or conjugated?
Get a free quote
CNY 5,729.00
货期*
5周
规格
Product images
Specifications
Product Data | |
Clone Name | 6E9 |
Applications | ELISA, IP |
Recommend Dilution | Flow Cytometry: The typical starting working dilution is 1/50 (Ref.1). Immunoassay. Immnoprecipitation: Ref.1. |
Reactivity | Mouse |
Host | Rat |
Clonality | Monoclonal |
Immunogen | Mouse recombinant TREM-2 protein |
Specificity | The monoclonal antibody 6E9 recognizes membrane-bound as well as soluble triggering receptor expressed on myeloid cells-2 (TREM-2). |
Formulation | PBS State: Purified State: Liquid 0.2 µm filtered Ig fraction Stabilizer: 0.1% BSA Preservative: 02% Sodium Azide |
Concentration | lot specific |
Conjugation | Unconjugated |
Storage Condition | Store undiluted at 2-8°C. |
Gene Name | triggering receptor expressed on myeloid cells 2 |
Database Link | |
Background | TREM-2 is a 26 kDa transmembrane glycoprotein that consists of a single extracellular immunoglobulin-like domain, a transmembrane region with a charged lysine residue and a short cytoplasmic tail. It associates with DNAX-activation protein 12 (DAP12) for signaling and function. TREM-2 is expressed on immature monocyte-derived dendritic cells. After activation by microbial products or tumor necrosis factor (TNF) and TNF-related proteins, dendritic cells downregulate the expression of TREM-2. TREM-2 is also expressed by osteoclasts and microglia, where it is involved in bone modeling and brain function, respectively. Another role of TREM-2 might be promoting the removal of apoptotic cells, organic matrix and macromolecules by microglia. Defects in TREM-2 are a cause of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), also called presenile dementia with bone cysts or Nasu-Hakola disease (NHD). TREM-2, like TREM-1, can be cleaved on the membrane to release a soluble form of TREM-2 (sTREM-2). Elevated levels of sTREM-2 in CSF of multiple sclerosis patients have been detected. This elevated level may inhibit the anti-inflammatory function of the membrane-bound receptor suggesting sTREM-2 to be a possible target for future therapies. |
Synonyms | TREM-2, Trem2a, Trem2b, Trem2c |
Reference Data |
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Customer
Reviews
Loading...